Checkpoint Therapeutics, Inc. Profile Avatar - Palmy Investing

Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candi…

Biotechnology
US, Waltham [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Checkpoint Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Checkpoint Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Checkpoint Therapeutics, Inc..

End of CKPT's Analysis
CIK: 1651407 CUSIP: 162828107 ISIN: US1628282063 LEI: - UEI: -
Secondary Listings
CKPT has no secondary listings inside our databases.